AlphaYou
Overview
Smart money at a glance
Filings to Sep 30, 2026Net buying: insiders sold $0 and bought $1.5M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$1.5M netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $22.48
- 52-wk high
- $27.98
- High
- $22.69
- 52-wk low
- $19.40
- Low
- $22.16
- Prev close
- $22.45
- Mkt cap
- $11.29B
- Volume
- 5.41M
- Fwd P/E
- 17.4x
- Beta
- 1.68
- P/S
- 2.2x
- P/B
- 1.7x
- Profit margin
- -4.0%
- Op margin
- +8.6%
- ROE
- -3.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ELAN filings
Are insiders buying or selling Elanco Animal Health (ELAN) stock?
Net buying: insiders sold $0 and bought $1.5M of ELAN stock on the open market in the 90 days to Sep 30, 2026, according to SEC Form 4 filings. The largest was Kurzius, Lawrence Erik (Director), who bought $936K. The latest filing was on Aug 21, 2026.
Which members of Congress have traded ELAN recently?
None. No member of Congress disclosed a ELAN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ELAN smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (3)
- CI
Citadel
$133.0M
added
- MI
Millennium
$50.0M
added
- MW
Marshall Wace
$76.0M
added
What insiders are doing
Buys (3)
- KL
Kurzius Lawrence Erik
$936K
bought
- OS
O'Neill Shiv
$94K
bought
- HM
Harrington Michael J
$109K
bought
How top traders are positioned
No tracked top-trader positions in ELAN right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 25.9% above what analysts expected.
Earnings per share
$0.27 expected
Reports Nov 4, 2026, in 35 days
Estimates as of Sep 29, 2026
EPS expected
$0.19 to $0.24
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.14B | $1.14B | $1.37B | $1.37B |
| Cost of what it sold | $530.0M | $694.0M | $586.0M | $570.0M |
| Gross profit | $607.0M | $450.0M | $785.0M | $798.0M |
| What it spent | ||||
| Research and development | $89.0M | $93.0M | $97.0M | $92.0M |
| Sales and admin | $351.0M | $338.0M | $381.0M | $449.0M |
| Other operating costs | $140.0M | — | — | $148.0M |
| Total operating expenses | $580.0M | $431.0M | $478.0M | $689.0M |
| What was left | ||||
| Operating profit | $27.0M | $19.0M | $307.0M | $109.0M |
| Interest on debt | $52.0M | $91.0M | $57.0M | $59.0M |
| Profit before tax | -$50.0M | -$259.0M | $87.0M | $56.0M |
| Tax | -$16.0M | $17.0M | $30.0M | $2.0M |
| Net profit | -$34.0M | -$276.0M | $57.0M | $54.0M |
| EBITDA | $178.0M | $6.0M | $316.0M | $274.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace